Skip to main content

Published locations for High-dose interferon offered no survival benefit in patients with melanoma and a single tumor–positive sentinel lymph node

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. High-dose interferon offered no survival benefit in patients with melanoma and a single tumor–positive sentinel lymph node

User login

  • Reset your password
  • /content/high-dose-interferon-offered-no-survival-benefit-patients-melanoma-and-single-tumor-positive
  • /edermatologynews/article/106396/melanoma/high-dose-interferon-offered-no-survival-benefit-patients
  • /oncologypractice/article/106396/melanoma/high-dose-interferon-offered-no-survival-benefit-patients
  • /hematology-oncology/article/106396/melanoma/high-dose-interferon-offered-no-survival-benefit
  • /dermatology/article/106396/melanoma/high-dose-interferon-offered-no-survival-benefit-patients